Skip to content
Search

Latest Stories

Thornton & Ross wins best campaign award

Thornton & Ross has won a prestigious industry award for one of its market-leading skin care products at the Pharma Intelligence OTC Marketing Awards, the company said in a statement.

The company was shortlisted for a total of eight awards across five categories awards held on Thursday.


It's product skin care product Cetraben received the award for Best OTC Public Relations Campaign for a Non-Medicine and, along with Covonia, it was highly commended in the Social Media Category.

Flexitol was highly commended in the Best Niche OTC Marketing Campaign.

Roger Scarlett-Smith, Thornton & Ross Executive Vice-President, said he hoped that the win for Cetraben would herald a successful start to the 2020 awards season for the company.

“The categories in which we are competing are open to any organisation across the UK, so we are in the company of some of the UK’s biggest brands. I am absolutely delighted at the success of the Cetraben campaign and hope that this win is the first of many,” Scarlett-Smith said.

Amy Brennan, Senior Brand Manager for Cetraben, added: “We were thrilled to be named as the winner in the Best OTC Public Relations Campaign for a Non-Medicine category. My thanks go to everyone on the team who worked so hard to help us achieve this richly deserved result.”

Thornton & Ross is part of the STADA Group.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less